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AIDS-related glomerulopathy: Occurrence in specific risk groups. The
histopathology and incidence of AIDS-related glomerulopathy was
evaluated by renal biopsy (N = 24) or at autopsy in 159 patients,
including 131 adults and 28 infants and children with AIDS. Thirty—five
patients had overt clinical manifestations of renal disease characterized
by a nephrotic syndrome with focal and segmental glomerular sclerosis
(FSS). Fifteen patients had diffuse glomerular mesangial hyperplasia
(MH) without or with minimal clinical renal disease and 109 had intact
or minimally involved glomeruli. Whereas 15 of 30(50%) i.v. drug users
with AIDS had evidence of renal disease, only one of 53 (2%) homo-
sexuals had clinical renal disease and only 6 (11%) had histologic
evidence of glomerular pathology. The study confirms the important
risk of i.v. drug use as a pathogenic factor of renal disease and shows a
rarity of renal disease in homosexual or bisexual men with AIDS. On
the other hand, 30% of adult Haitians with AIDS had FSS or diffuse
MH, although i.v. drug use is not an important risk factor in this
population. Moreover, eight of 28 (29%) children with perinatal AIDS
had evidence of renal involvement, including four with a nephrotic
syndrome and FSS. The data provide strong evidence for the existence
of an AIDS-related glomerulopathy independent of i.v. drug use, but
suggest that unrecognized co-factors may be important in the develop-
ment of renal disease.
The acquired immune deficiency syndrome (AIDS) is char-
acterized by a marked abnormality in cellular immunity asso-
ciated with recurrent opportunistic infections and/or Kaposi's
sarcoma [1]. Some patients develop intercurrent acute renal
insufficiency as a result of disturbances in extravascular volume
or nephrotoxicity secondary to drug treatment or diagnostic
studies. Chronic renal disease manifested by overt proteinuria
and/or renal insufficiency associated with lesions of focal and
segmental glomerular sclerosis (FSS) has also been reported
[2-4].
On the other hand, glomerular lesions have not been de-
scribed in several autopsy series which reviewed the systemic
lesions of AIDS [5—101. Moreover, a preliminary study con-
cerned specifically with the renal manifestations of AIDS in 50
autopsied homosexual males failed to reveal significant glomer-
ular abnormalities [11]. Other factors such as i.v. drug use or
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delayed treatment were considered responsible for the previ-
ously reported glomerular pathology in patients with AIDS.
In 1984, we reported five patients with AIDS and FSS, four of
whom had the nephrotic syndrome; two other patients had
diffuse mesangial hyperplasia (MH) [3]. The present study
reports our experience to date, and extends our previous
clinicopathologic observations to 131 adults and 28 children
with AIDS or AIDS-related complex (ARC) seen since 1982 in
whom renal tissue was examined. The results support an
association between AIDS and a glomerulopathy with evidence
of focal and segmental sclerosis or diffuse mesangial hyperpla-
sia (MH). Such pathology was present in a considerable number
of patients in the absence of i.v. drug use as a risk factor and in
children with perinatally acquired AIDS. Glomerular lesions of
FSS were also encountered in patients with ARC who clinically
presented with apparently primary renal disease and a ne-
phrotic syndrome but went on subsequently to develop the
clinical complications of AIDS. The study also confirms the
rarity of renal involvement in homosexuals with AIDS.
Methods
In January 1982, a prospective evaluation of all patients with
AIDS was begun at our medical center. This report includes 159
patients with AIDS or ARC from whom renal tissue was
available for study. All were admitted to the University of
Miami—Jackson Memorial Medical Center between January 1,
1982 and March 31, 1986. A renal biopsy was obtained in 24
patients. Renal tissue was separately obtained in another 135
patients with AIDS from consecutive autopsies performed in
1983, 1984 and 1985.
The medical record of each patient was carefully reviewed
with particular emphasis on sociological data, diagnostic pro-
cedures, infectious complications and therapeutic interven-
tions. The following groups at risk were considered in adults: 1)
patients who used parenteral drugs; 2) homosexual or bisexual
men; 3) heterosexual women of a partner identified as having
AIDS; 4) patients who received contaminated blood; and 5)
patients with none of the above risk factors identified. Thirty—
six of the 41 patients composing the latter group were Haitians.
Criteria for diagnosing AIDS or ARC and risk factors were
those defined by the Center for Disease Control [121. ARC is
defined by the presence of constitutional symptoms or physical
findings compatible with AIDS, barring demonstration of op-
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portunistic infections or Kaposi's sarcoma. In addition, since
1985, demonstration of circulating antibodies against human
immunodeficiency virus (HIV) has been required to establish
the diagnosis. Similarly, criteria for defining opportunistic in-
fections followed the guidelines of the Center for Disease
Control with the diagnosis established by culture or identifica-
tion of the etiologic agent in body fluids, biopsy specimens or
samples obtained postmortem [121. The criteria for diagnosing
classic Kaposi's sarcoma or the inflammatory variant were
previously described [13].
T lymphocyte subsets were quantitated using commercial-
ly—available monoclonal antibodies (Ortho Diagnostic Systems
Inc., Raritan, New Jersey, USA) on a fluorescence—activated
cell sorter (FACS IV; Becton—Dickinson Monoclonal Center
Inc., Sunnyvale, California, USA) [14]. The presence of serum
antibodies against HIV (human 1-cell lymphotropic virus Type
III (HTLV-III) or lymphadenopathy—associated virus (LAY)
was tested by ELISA and confirmed by Western blot analysis
for patients in unrecognized risk groups. Routine chemistries
were performed by the clinical laboratories of University of
Miami—Jackson Memorial Medical Center. Serum creatinine
was measured by the rate method of Jaffe adapted to the Astra
8 Beckman Analyzer (Beckman Instruments, Fullerton, Cali-
fornia, USA) [15]. Urinary protein was determined qualitatively
with Multistix (Miles Laboratories, Elkhart, Indiana, USA) and
measured quantitatively by the turbidimetric method of Iwata
and Nishikaze adapted to the ACA Du Pont Clinical Analyzer
(DuPont Co., Wilmington, Delaware, USA) [16].
Renal biopsy samples were fixed in Karnovsky's solution [17]
and autopsy specimens in buffered formalin. For each patient,
histologic sections were stained with hematoxylin and eosin and
periodic acid—Schiff. In a majority of patients, samples were
postfixed in osmium tetroxide and embedded in Epon or
Polybed. Semi-thin sections from several glomeruli and thin
sections from two representative glomeruli were examined by
electron microscopy. Kidney tissue from 15 random autopsies
with similar postmortem intervals were identically processed to
serve as controls for postmortem autolytic changes.
Cryostat sections from biopsy and autopsy specimens of
renal tissue previously fixed in Michel's solution [18] were
studied by direct immunofluorescence using standard proce-
dures with commercially available antibodies to human immu-
noglobulins and the third component of the complement system
(C3) (Melloy Laboratories, Springfield, Virginia, USA). The
autopsy sections were compared for nonrelevant localization of
reactants with randomly—selected control autopsies and simi-
larly—processed kidney sections from 20 autopsies matched for
time after death.
The diagnoses of mesangial hyperplasia and glomerular scle-
rosis were made by light microscopy. Only evidence of diffuse
mesangial hyperplasia was considered abnormal for the purpose
of this report and was defined by an increase in mesangial cells
represented by more than three nuclei in mesangial stalks of
more than 50% of glomeruli. In this category, patients 34, 35
and 39 of Table 1 were previously reported (patients 6 through
8 in ref. 3). Previously reported patients with focal (patients 9
through 13 in ref. 3) or minimal (patients 14 through 17 of ref. 3)
mesangial hyperplasia are included in Table 1 among the group
of patients without or with minimal glomerular changes that
were not considered significant in this study.
Glomerular sclerosis was diagnosed when excess production
of mesangial matrix associated with capillary obliteration re-
sulted in solidification of one or several lobules. The presence
of hyalinosis was not required [19].
Three degrees of FSS were considered in the spectrum of the
lesions observed. In early lesions, diffuse mesangial hyperplasia
predominated with disperse and minute changes of FSS. The
interstitium usually exhibited an obvious interstitial infiltrate
with a predominance of lymphocytes and plasma cells. A focal
and segmental sclerosis with abundant hyaline casts and numer-
ous hyaline droplets in the proximal tubular epithelium were
characteristics of established lesions. Glomerular epithelial
cells appeared swollen and contained conspicuous hyaline
droplets. The interstitial infiltrate was abundant in many in-
stances with areas of interstitial fibrosis and tubular atrophy.
Advanced lesions consisted of diffuse segmental and global
glomerular sclerosis associated with markedly dilated tubules,
which contained large variegated casts which predominated in
the medullary rays. Many glomeruli were reduced to stumps
surrounded by a crown of hypertrophic visceral epithelial cells
containing prominent hyaline droplets. Bowman's space was
frequently dilated. The infiltrate was now a minor component of
the interstitial lesion which frequently appeared edematous and
replaced with a homogenous, acidophilic ground substance.
Results
Table 1 presents selected clinical and pathologic data for 131
adults with AIDS/ARC. Histology was determined from biopsy
specimens in 20 instances and from autopsy samples in 117
patients. Patients with abnormal glomerular histology are listed
individually. Only the primary risk factor is listed. Multiple risk
factors were identified in seven i.v. drug users who also were
homosexual or bisexual (patients #28 and 34, and five patients
with normal glomeruli).
A diagnosis of FSS was established in 31 patients (Table 1).
This group of patients was 33.2 1.2 years old (range 24 to 55
years). Nineteen patients (61%) were male; four were white
(13%), and 27 were black of whom 12 (39%) were of Haitian
extraction. Nine patients had ARC and 22 had AIDS. Risk
factors for HIV infection included i.v. drug use in 14 patients
(45%), homo- or bisexuality in one (3%), heterosexuality in four
(13%), blood transfusions in one (3%) and remained undeter-
mined in 11 patients (35%) including 10 Haitians. Patients with
AIDS had an average of 2.2 0.2 opportunistic infections.
Seven patients (23%) had Kaposi's sarcoma. Survival averaged
14.1 1.7 months (range 1 to 43 months) from the time
constitutional symptoms developed until death or at last
follow—up. Seven patients are alive, of whom five carry the
diagnosis of ARC.
Except for three patients (#1, 5, and 27) in whom early FSS
was uncovered at autopsy, all patients had clinically—overt
renal disease manifested as 3+ proteinuria or proteinuria in
excess of 3 g/24 hrs and/or increased serum—creatinine concen-
tration. Mean proteinuria averaged 7.2 1.5 g/24 hrs with a
range of 1.6 to 37 g/24 hrs. Mean serum creatinine averaged 5.4
0.6 with a range of 1.0 to 10 mg/dl.
The diagnosis of FSS was made at autopsy in 18 cases
and/or by renal biopsy in 19. Six patients who had a renal
biopsy were also examined postmortem. At autopsy, kidneys of
patients with FSS were usually grossly enlarged. Mean two—
Table 1. Clinical and pathologic data in adults with AIDS/ARC
Opportu-
Patient
Age/a
sex
yrs Raceb
Diag-
nosis
Riska
factor
nisticd
infec-
tions
Kaposi's
sarcoma
Durationa
months Outcome
Urine1
protein
g/24 hr
Serums
creatinine
ing/di
Kidney'
weight g
Glomerular lesions
LM EM IF
Patients with focal and segmental glomerular sclerosis
I 55/F White AIDS Blood 3 — 15 Dead 1+ 1.6 — EARLY +
2 49/M Black(H) ARC IVD 0 — 16 Alive 2.0 3.0 — EST.* + +
3 47/M Black AIDS IVD I — 9 Dead 4.0 5.4 600 ADV.
4 44/F Black ARC Heterosex 0 — 4 Dead 2.3 2.7 — EARLY* + +
5 40/F Black(H) AIDS Unknown 5 + 10 Dead Trace 1.1 370 EARLY +
6 39/F Black ARC IVD 0 — 9 Alive 4.1 4.8 — EARLY* + +
7 38/M Black IVD a) 0 — 18 3.0 2.0 — EST* + +
AIDS b) 2 + 34 Dead 9.0 I-ID — EST
8 37/M Black ARC Unknown a) 0 — 18 4.0 HD — ADV.* — +
ARC b) 0 - 23 Dead HD — ADV.
9 37/F Black(H) AIDS Heterosex 3 — 22 Dead 3.4 HD 235 ADV. +
10 36/M Black ARC Homosex 0 — 12 Alive 1.6 5.4 — ADV.* + —
11 36/F Black AIDS Heterosex 2 — 12 Dead 20 3.2 430 EST. + +
12 36/M Black AIDS IVD 2 — 24 Alive 9 2.8 — ADV.* +
13 35/F Black(H) AIDS Unknown 2 + 4 Dead 1.6 HD 520 EST.
14 34/M Black AIDS IVD 3 — 4 Dead 9.2 5.1 — EARLY* — +
15 34/F Black AIDS Heterosex 2 + 22 Dead 3+ 1.5 420 ADV. —
15 33/M Black AIDS IVD I — 7 Dead 7.3 2.0 — EARLY* — +
17 33/M Black AIDS IVD 4 — 16 Dead 3.2 6.8 730 ADV. + +
18 33/M White AIDS IVD a) 2 — 6 2+ 6.2 — ADV.*
AIDS b) 2 - 8 Dead HD — ADV.
19 31/M White ARC IVD 0 — IS Alive 22 2.1 — EST.* + +
20 31/F Black(H) AIDS Unknown 2 — 2 Dead 2.6 HD 930 ADV.
21 30/M Black AIDS IVD 2 — 24 Alive 10 HD — ADV.* — +
22 29/M Black AIDS IVD 2 — 8 Dead 1.7 6.6 — EST.
23 29/M Black(H) AIDS Unknown 2 — I Dead 6.9 7.5 — EST.* + +
24 27/F Black(H) ARC Unknown 0 — 12 Alive 2.0 1.1 — EST.*
25 27/M Black(H) AIDS Unknown a) I — I 4.2 2.7 — EST.* + +
AIDS b) 2 + 7 Dead 6.6 440 ADV.
26 26/F Black ARC IVD a) 0 — 19 6.6 2.0 — EST.* + +
ARC b)0 — 22 Dead 11.1 HD 470 ADV.
27 25/M Black(H) AIDS Unknown 2 + 22 Dead Trace 1.3 450 EARLY —
28 25/M White AIDS IVD 2 + 6 Dead 22 2.7 240 ADV. + +
29 25/M Black(H) AIDS Unknown a) I — 1 1.3 — EARLY* + +
AIDS b) I — 12 4.2 5.9 — EST.*
AIDS c) 3 — 18 Dead Trace HD 500 ADV.
30 24/F Black(H) ARC Unknown 0 — 43 Dead 14 1.4 — ADV.* — +
31 25/M Black(H) AIDS Unknown 2 — 6 Dead 37 HD — ADV.* — +
Mean 33.2 see 2.2 7+ 14.1 7.2 5.4 487 + 15/22 +20/22
SE text
Patients with diffuse glomerular mesangial hyperplasia
32 56/M Black AIDS Homosex 3 + 4 Dead .34 1.6 230 MH +
33 48/M White AIDS Homosex 2 + 11 Dead negat 0.8 300 MH +
34 40/M White AIDS IVD 6 — 24 Dead negat 1.5 200 MH + +
35 39/M White AIDS Homosex 0 + 18 Dead 1+ 1.1 535 MH + +
36 39/M White AIDS Homosex 4 — 2 Dead negat 0.7 520 MH — +
37 37/M White AIDS Homosex 2 — 13 Dead negat 1.0 280 MH
38 35/M Black(H) AIDS Unknown I + 5 Dead 2+ 0.6 330 MH +
39 34/M Black(H) AIDS Unknown 2 — 4 Dead I 360 MH
40 29/F Black AIDS Heterosex 2 + 3 Dead negat 0.8 270 MH + +
41 29/M Black(H) AIDS Unknown I + I Dead 1+ 1.4 275 MH
42 27/F Black AIDS Unknown 2 + 6 Dead Trace 0.8 330 MH
Mean 37.5 2.3 7+ 8.3 All 1.0 330 +5/6 +5/5
dead
Patients with normal or minimal glomerular changes (N=89)
Mean 37.2 see All see 2.8 59+ 9.1 All see 1.6 330 +15/50 +28/43
text AIDS text ±0.2
a Age at time of death or at last follow—up b (H) means Haitian origin Risk factors are listed hierarchically in the following order: IVD for
parenteral drug use, homosex for homosexual or bisexual men, heterosex for women with heterosexual contacts with a partner(s) with proven
AIDS (patients # 4, 9, 11, 15 and 40) in the absence of other risk factor, blood for recipients of blood transfusions or blood products, and unknown
for patients with none of the above risks identified. Patients with multiple risk factors are tabulated only in the group listed first. d Mean data
include only patients with AIDS. e Duration of ARC or AIDS is defined from appearance of constitutional symptoms to time of death or time of last
follow—up Value closest to the time of renal tissue examination. Mean 5E was calculated using 0.5 g/24 hr for the 6 patients with FSS in whom
proteinuria was not quantitated. g Value closest to the time of renal tissue examination; HD means patient on hemodialysis. Mean s was
calculated using a serum creatinine of 10 mg/dl for patients on hemodialysis. h Weight of two kidneys. See text for definition of glomerular lesions;
LM indicates light microscopy; EM indicates electron microscopy and IF indicates immunofluorescence microscopy; * indicates renal biopsy;
renal tissue from other patients was obtained at autopsy; presence or absence of mesangial deposits on EM or IF is indicated by + or —,
respectively; blank space indicates test not done.
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Fig. 1. Glornerulus in a patient with FSS and AIDS. There is solidifi-
cation of one lobule surrounded by a crown of epithelial cells (estab-
lished lesion—short arrow) and an early sclerotic lesion with capillary
collapse and distortion (long arrow). Fushion of capillary wall to
Bowman's capsule is also seen in this area. P.A.S. stain. Original
magnification x450.
kidney weight for the group averaged 487 51 g. At last
examination, the evidence of FSS consisted of early lesions in
seven patients, established lesions in eight and advanced le-
sions with global sclerosis in 16. Representative examples of
established and advanced lesions of FSS are depicted in Figures
1 and 2.
Electron microscopy performed in 22 instances revealed
mesangial dense deposits and/or luminal insudative lesions in
scierosed lobules in 15 patients (68%). Immunofluorescence
examination, also of 22 cases, showed mesangial deposits of
1gM or C3 in 20 instances (90%).
The glomerulopathy in eleven other adults with AIDS was
characterized by diffuse mesangial hyperplasia (Table 1). These
patients averaged 37.5 2.6 years (range 27 to 56 years); nine
(82%) were male; five (45%) were white and six were black, of
whom three (27%) were Haitians. All had AIDS. Risk factors
were identified as i.v. drug use in one (9%), homosexuality in
five (45%), heterosexuality in one (9%) and remained undefined
in four patients (36%), including three Haitians. These patients
had an average of 2.3 0.5 opportunistic infections and seven
(64%) had Kaposi's sarcoma. They survived an average of 8.3
2.3 months. None of the patients with MH developed
clinically—overt renal disease, and the glomerulopathy was
identified at autopsy in all patients. Proteinuria was modest and
none had a serum creatinine greater than 2 mg/dl at death. At
autopsy, mean two—kidney weight averaged 330 32 g.
Glomerular mesangial deposits were identified by electron
microscopy in five of six patients (83%) and by immunofluores-
cence in five of five (100%).
A third group of adults, all with AIDS, consisted of 89
patients with histologically normal glomeruli at autopsy (Table
1). Average age was 37.2 1.1 years (range 20 to 65 years).
Seventy—five (84%) were male. Fifty—two (58%) were white and
36 were black, including 23 (26%) Haitians. Risk factors in-
Fig. 2. Advanced glomerular lesion in a patient with FSS and AIDS.
The glomerulus shows global sclerosis and collapse associated with
dilatation of Bowman's space. Dilated tubules with variegated casts are
prominent. Hematoxylin and eosin stain. Original magnification x235.
cluded i.v. drug use in 15 patients (17%), homosexuality in 47
(53%), blood transfusion in one (1%) and remained undefined in
26 (29%), including 23 Haitians. These patients developed an
average of 2.8 0.2 opportunistic infections and 59 (66%) had
evidence of Kaposi's sarcoma. Average survival was 9.1 0.7
months with little evidence of clinical renal disease. All but
three had proteinuria less than 3 + or 3 g/24 hr. Terminally,
serum creatinine rose above 2 mg/dl in 15 of them. Mean
two-kidney weight averaged 330 9 g (N = 83). Glomerular
mesangial deposits were evident in 15 of 50 patients (30%) by
electronmicroscopy and in 28 of 43 (65%) by immunofluores-
cence.
Table 2 presents data for 28 infants and children with AIDS.
All patients were black and 19 (68%) were Haitian. Four
children (14%) developed a nephrotic syndrome with evidence
of FSS on renal biopsy. Proteinuria was important in all four
and serum creatinine increased chronically in one. These pa-
tients ranged in age from 24 to 60 months. They had developed
an average of two opportunistic infections. None had Kaposi's
sarcoma and three are alive at last follow—up.
Another four children, aged 7 to 36 months, had evidence of
diffuse, glomerular mesangial hyperplasia at autopsy without
clinical or biochemical manifestations of renal disease (Table 2).
They also suffered an average of two opportunistic infections,
and three of them had evidence of Kaposi's sarcoma. For the
eight children with abnormal glomerular histology, mesangial
deposits were observed in five of six (83%) by electron micros-
copy and in three of four (75%) by immunofluorescence.
The kidneys of 20 other infants and children with AIDS were
examined at autopsy; glomeruli were normal or exhibited only
focal changes of mesangial hyperplasia on light microscopic
examination (Table 2). These children had an average age of
15.3 3.5 months (range ito 60 months) and developed 1.9
0.2 opportunistic infections. Eleven (55%) had Kaposi's sar-
coma. None had more than 2+ proteinuria, and serum creati-
nine concentration was normal although it terminally exceeded
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Table 2. Clinical and pa thologic data in children with perinatal AIDS
Age/sex Opportunistic Kaposi's
Patient months Race infections sarcoma
Duration
months Outcome
Urine
protein
g/24 hr
Serum
creatinine
ing/di
Kidney
weight g
Glomerular lesions
LM EM IF
Patients with focal and segmental glomerular sclerosis
36 Dead 3.7 0.5 EARLYb — +1 60m/M Black 4 — —
2 48m/F Black 2 — 45 Alive 3.4 1.1 — ADV.b + +
3 36m/M Black(H) I — 30 Alive 0.4 0.4 — EARLYb + —
4 24m/F Black I — 16 Alive 3.2 0.2 EST.b +
Patients with diffuse glomerular mesangial hyperplasia
20 Dead Trace 0.5 MH5 36m/F Black(H) 2 — —
6 8m/F Black(H) 2 + 7 Dead negat 0.4 75 MH + +
7 7m/M Black(H) 3 + 4 Dead negat 0.4 68 MH +
8 8m/M Black(H) I + 7 Dead Trace 0.3 80 MH
Patients with normal or minimal glomerular changes (N=20)
7.0 All All 0.78 69.3 +2/6 +5/7Mean 15.3 see 1.9 11+
text dead 2+
Abbreviations are the same as Table I.
a Identified in the absence of blood or blood product transfusion. Risk factor was identified in mother as IVD use for patient 4, mother with AIDS
or HTLV-III seropositivity for patients 1, 2 and 8, and was not identified for patients 3, 5—7.
b indicates renal biopsy
1 mg/dl in four patients. Mesangial deposits were evident in two
of six (33%) specimens examined by electronmicroscopy and in
five of seven (7 1%) examined by immunofluorescence.
Discussion
A relationship between AIDS and a glomerulopathy mani-
fested histologically as FSS was first described by Rao et a! [2]
on the basis of observations in eleven patients. Six of their
patients presented without an etiopathogenic entity known to
be associated with FSS. We made the same observation in five
patients with AIDS and the nephrotic syndrome and also
observed a high incidence of glomerular mesangial hyperplasia
in the AIDS population [3].
However, the lack of specificity of FSS and the high inci-
dence of AIDS in i.v. drug users, a condition well known by
itself to result eventually in FSS [20], raises the possibility that
FSS in AIDS may be related to i.v. drug use by patients who
would not acknowledge such practice. Indeed, in contrast to the
reports issued from the East coast of the United States, FSS has
not been associated with AIDS on the West coast of the United
States, despite the severe AIDS epidemic ongoing in cities such
as Los Angeles or San Francisco (M. Humphreys and P.
Schoenfeld, personal communication). Moreover, several au-
topsy series also do not mention glomerular abnormalities in a
composite of 137 patients with AIDS of whom 121 were
homosexuals [5—10]. Balow, Macher and Rook [11], looking
specifically for renal abnormalities associated with AIDS in a
systematic postmortem examination of 50 homosexual men,
failed to observe any patient with renal disease and FSS.
In contrast to the homogeneous population of homosexual or
bisexual patients with AIDS observed on the West Coast, the
AIDS population in New York and in Miami is composed of
several groups at risk. When considering these various groups,
the present study explains the above apparent paradox. Figure
3 depicts the incidence of patients with FSS, diffuse MH or
normal glomeruli identified among our different groups of adult
patients with AIDS/ARC. The data confirm the important risk
of i.v. drug use as a pathogenic factor of renal disease. Fifty
Homosexual Heterosexual Undefined
Risk factor
Fig. 3. Incidence of glomerulopathy among different groups of adults
with AIDS/ARC as a function of risk factor for AIDS. Number at the
foot of each bar refers to number of patients. Symbols are: () FSS or
MH; (0) normal glomeruli.
percent of 30 IVD users with AIDS had evidence of renal
disease, 14 with FSS and one with MH. In contrast, clinical
renal disease with the nephrotic syndrome was rarely seen in
homosexuals with AIDS. Among 53 homosexuals, only one
(2%) developed chronic renal disease clinically, and only six
(11%) had evidence of renal involvement histologically. Pa-
tients acquiring AIDS heterosexually also appear more likely to
develop clinical renal disease with five of five (100%) develop-
ing FSS. Thirty—six of the 41 patients with undefined risk
factor(s) were Haitian; 15 (36%) had renal involvement, includ-
ing 10 with FSS.
Thirty—nine (30%) adults and 19 (68%) infants and children
with AIDS were Haitians. Fully one—third and 21%, respec-
tively, had clinical renal disease. One adult acknowledged
homosexuality, another i.v. drug use, and a third was the
heterosexual partner of a patient with AIDS; in 36, a risk factor
for AIDS was not identified. Heterosexuality may have been an
important route of transmission of the AIDS virus among the
nine women and 27 men of Haitian extraction in whom the risk
factor for AIDS remained undefined [21]. One may argue that
100
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0
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Table 3. Comparison between IVD users, homosexuals and adult
Haitians with AIDS/ARC
IVD
Users
N=30
Homosexuals
N=53
Haitians
N=38
Age 35.5 1.6 38.5 1.4 33.1 1.4
Male 21(70%) 53 (100%) 26 (68%)
Black 18(60%) 6(11%) 38(100%)
Clinical renal disease 14 (47%) I (2%) 12 (32%)
Histologic glomerulopathyb 15 (50%) 6 (11%) 15 (39%)
Duration of diseasea 10.7 1.6 8.6 0.8 11.1 1.4
N. Opportunistic infections 2.3 0.3 2.5 0.2 2.6 0.2
Pneumocystis 15 (50%) 28 (52%) 14 (37%)
Toxoplasmosis 2 (7%) 8 (15%) 8 (21%)
Cytomegalovirus 8 (27%) 18 (34%) 13 (34%)
Herpes virus 7 (23%) 12 (23%) 6 (16%)
Disseminated candidiasis 11(37%) 8(15%) 6(16%)
Tuberculosis 6 (20%) 12 (23%) 24 (63%)
Kaposi's sarcoma 11(37%) 38 (72%) 16 (42%)
Values are means SE
b Defined as either FSS or diffuse MH
Haitians do not acknowledge illicit i.v. drug use or that renal
disease in Haitians with AIDS results from parenterally admin-
istered medications. This is an unlikely explanation. The i.v.
use of illicit drug is not an important risk factor, averaging 1 to
4 percent among Haitians with AIDS [22, 23]. Only one such
patient (#2), who was also a prostitute, was identified in this
series. Physical examination of Haitians with AIDS does not
reveal evidence of active or prior usage of drugs. The practice
of attending local clinics for parenteral injections also is no
more prevalent among Haitians with AIDS than in Haitians
without AIDS in Miami (M. Fischl, M.D., personal communi-
cation).
Homosexuality is not commonly claimed among Haitians and
only one patient (with normal glomeruli) admitted to homosex-
uality in this series. Nevertheless, bisexuality in Haiti was
recently found in 50% of 26 males with AIDS [23]. Even such a
prevalence would not, however, explain the high incidence of
renal disease among Haitians with AIDS since renal disease is
remarkably absent among homosexuals in this and in other
series [5—10].
FSS, as a primary renal disease, also is not prevalent among
the 50000 to 60000 Haitians living in Miami. Of eight renal
biopsies performed on Haitian patients in the past two years at
our institution, all but one were performed on patients who
ultimately proved to have AIDS/ARC.
Parenteral drug use can be excluded in infants and children.
Nevertheless, the incidence of renal pathology among children
was the same, about 30%, as in adults. Eight children or 29%
had histologic evidence of renal involvement, including four
who developed the nephrotic syndrome with FSS.
Thus, two—thirds of the patients with AIDS and FSS or
diffuse MH were not i.v. drug users. Transmission of the HIV
infection in these renal patients was traced to heterosexual or
perinatal routes or remained undefined. Moreover, although we
do not know the incidence of renal disease in our population of
current i.v. drug users without AIDS, the high incidence of
renal pathology in i.v. drug users who have AIDS appears to far
exceed the incidence of renal disease in i.v. drug users who do
not have AIDS. In these, the occurrence of a nephropathy has
been described with an incidence varying from 3.5% to 10% in
hospitalized [24] and in autopsied addicts [25], respectively.
Thus, whereas the data confirm the rarity of renal disease in
homosexual or bisexual men with AIDS, this study provides
strong evidence for the existence of an AIDS-related
glomerulopathy which is not associated with i.v. drug use. The
glomerulopathy is characteristic, though not specific, and is
undistinguishable histologically in AIDS and in i.v. drug users.
In both instances, the renal lesion appears aggressive with an
often—abundant interstitial infiltrate of lymphocytes and plas-
mocytes, hypertrophied glomerular—epithelial cells with hyaline
droplets and large variegated tubular—casts. The clinical course
to end—stage renal failure is usually accelerated in AIDS [2]
The nature and significance of mesangial deposits in AIDS
has not been determined. Glomerular deposits are considered to
show localization of pathogenic immune complexes. The pres-
ence of circulating immune complexes in most patients with
AIDS supports this interpretation [3]. However, glomerular
deposits of 1gM or C3 may occur in patients with hypertension
or diabetes mellitus in whom an immune mechanism is not
implicated as part of the pathogenesis of the renal disease. Also,
in our patients, mesangial deposits were frequently seen in
patients with AIDS who had histologically normal glomeruli.
Why renal disease occurs more readily in certain groups of
patients with AIDS and not in homosexuals remains unknown.
It may be that different viruses with different renotropism are
responsible for AIDS in specific risk groups. Viral disease is
seldom associated with an overt glomerulopathy in humans.
Alternatively, if the same virus is responsible for AIDS among
the different groups at risk, the study would suggest that the
virus itself may not be directly nephrotoxic, but that co-factors
are important determinants in the expression of the renal
disease. To examine this possibility, the groups of adults with
AIDS and i.v. drug use or homosexuality as a risk factor and the
group of Haitian patients with AIDS were compared (Table 3).
The identity of possible co-factors remains obscure. No differ-
ences between the three groups were found with regard to age,
duration of the disease, the incidence and types of major
opportunistic infections. Moreover, in several patients, the
nephrotic syndrome and FSS preceded any opportunistic infec-
tion.
The incidence of typical or atypical tuberculosis was higher in
Haitians than in i.v. drug users or homosexuals. The differences
may simply reflect an increased exposure of Haitians to tuber-
culosis. Tuberculosis is widespread in the Haitian community in
Miami. Immunodeficiency in that community, therefore, should
be expected to be associated with a parallel increase in the
incidence of tuberculous infection [26]. Overall, however,
whereas the incidence of tuberculosis was two- to threefold
higher in Haitians than in i.v. drug users or in homosexuals,
tuberculosis was seen with the same frequency in Haitians with
AIDS without renal disease (15 of 24 or 63%) as in Haitians with
AIDS and renal disease (9 of 15 or 60%).
The apparent lesser incidence of Kaposi's sarcoma in Hai-
tians and in i.v. drug users compared to homosexuals is
interesting. This difference may reflect the fact that only 60% of
patients with FSS were autopsied, as opposed to all patients
with MH or normal glomeruli where homosexuals were a
majority. Kaposi's sarcoma, whether classic or inflammatory,
AIDS-related glomerulopathy 1173
remains unrecognized until autopsy in almost 80% of patients
with AIDS [13]
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